MIL:ERFO'
s EV-to-FCF Range Over the Past 10 Years
Min: -71.39 Med: -8.05 Max: 19.95
Current: -6.38
During the past 7 years, the highest EV-to-FCF of Laboratorio Farmaceutico Erfo SpA was 19.95. The lowest was -71.39. And the median was -8.05.
MIL:ERFO's EV-to-FCF is ranked worse than 100% of 1188
companies
in the Consumer Packaged Goods industry
Industry Median: 15.405
vs MIL:ERFO: -6.38
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Laboratorio Farmaceutico Erfo SpA's PE Ratio (TTM) for today is calculated as:
Laboratorio Farmaceutico Erfo SpA's share price for today is €1.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Laboratorio Farmaceutico Erfo SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.044.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Laboratorio Farmaceutico Erfo SpA EV-to-FCF Related Terms
Laboratorio Farmaceutico Erfo SpA EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's EV-to-FCF falls into.
Laboratorio Farmaceutico Erfo SpA's current Enterprise Value is €10.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Laboratorio Farmaceutico Erfo SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-1.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a EV-to-FCF of -6.51 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #999999 out of 1188 companies in the Consumer Packaged Goods industry.
Is Laboratorio Farmaceutico Erfo SpA's EV-to-FCF too high?
Laboratorio Farmaceutico Erfo SpA's current EV-to-FCF is -6.51. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #999999 out of 1188 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #999999 out of 1188 companies for EV-to-FCF. This places Laboratorio Farmaceutico Erfo SpA in the lower half of its industry. The industry median EV-to-FCF is 15.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.41, based on 1,188 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current EV-to-FCF is -6.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.10, compared to a current price of €1.18 — trading 43.8% below its estimated fair value. The current EV-to-FCF is -6.51. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current EV-to-FCF is -6.51 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.18 is trading 43.8% below its estimated GF Value™ of €2.10.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
EV-to-FCF: -6.51
GF Value™: €2.10 vs. price of €1.18 (43.8% below fair value)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA Business Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
68GF Score
Get the complete analysis for MIL:ERFO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 
